Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs Potere Health MD

By GLP-1 ScorecardUpdated

Eden
Site position #16

Higher score

Potere Health MDFactor scores not reassessed.
Site position #87

Lower score

Score comparison

Eden has the higher recorded score — 81.6/100 to 72.5/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Before you choose

Before comparing the headline prices, the Eden review and the Potere Health MD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Eden vs Push Health and Effecty vs Potere Health MD compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEven
85
85
Dose & formulationEden +22
86
64
Clinical oversightPotere Health MD +32
55
87
Labs & monitoringEden +38
92
54
FulfillmentEden +26
93
67
Contract termsEden +29
90
61
Eden · top barPotere Health MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenPotere Health MD
WeighScore81.6/10072.5/100
GradeB−C
Site position#16#87
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkout$239 upfront for the advertised 10 mg compounded vial; usable supply varies
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkout$119 for the advertised four-week compounded starting order or $350 upfront for the larger vial
CoverageAll 50 states1 state
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
Potere Health MD

Site position #87 · C

Factor scores not reassessed.

Strengths

  • Posts upfront purchase amounts for compounded options
  • Advertises Utah telehealth and in-person appointments
  • Discusses branded options separately

What to consider

  • Monthly estimates are not the amount due at purchase
  • Usable supply depends on the prescription and pharmacy label
  • Ask which charges and refund rules apply to the selected order

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard